IRCT2017081635732N1招募中1 期
Effect of oral fenofibrate on serum bilirubin level in term neonates with hyperbilirubinemia.
Vice- Chancellor for Research Technology Affairs, Babol University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 day 至 28 days（—）
- 性别
- All
入选标准
- •full-term newborns, with of age of more than 72 hour and serum bilirubin level more than 15 mg/dl.
- •Exclusion criteria: Preterm infants, IUGR, Congenital anomaly, Respiratory distress, sepsis.
排除标准
- 未提供
研究者
相似试验
Unknown
不适用
Role of Fenofibrate in Indirect Neonatal Hyperbilirubinemia: a Randomized Control TrialHyperbilirubinemia, NeonatalNCT04868019Shaheed Zulfiqar Ali Bhutto Medical University60
已完成
3 期
Fenofibrate in PSCIRCT20200427047225N1Shahid Beheshti University of Medical Sciences30
已完成
不适用
Prevention effect of fenofibrate/pioglitazone in obese diabetic patientsNutritional, Metabolic, EndocrineT2DM, obesityPACTR201407000856135faculty of pharmacy, ain shams university60
进行中（未招募）
4 期
Effect of Fenofibrate on Endothelial Dysfunction and Oxidative Stress in patients with Type 2 Diabetes Mellitus: an open label studytype 2 diabetes mellitusMetabolic and Endocrine - DiabetesACTRN12612000734864ita Cristina27
已完成
3 期
Effect of fenofibrate in the treatment of neonatal jaundiceeonatal jaundice.Neonatal jaundice from other and unspecified causesIRCT20201209049660N1Technology and Research Vice-chancellery, Hormozgan University of Medical Sciences86